Measurement of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 after delayed separation of whole blood samples

Clinical Biochemistry

Volumn 41, Issue 7-8, 2008, Pages 636-639

  Hartog, Hermien ^a   van der Graaf, Winette T A ^b   Wesseling, Jelle ^c   van der Veer, Eveline ^a   Boezen, H Marike ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

Author keywords

IGF 1; IGFBP 3; Plasma; Serum; Stability; Storage; Whole blood

Indexed keywords

EDETIC ACID; HEPARIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; BLOOD STORAGE; CONTROLLED STUDY; FEMALE; HUMAN; PRIORITY JOURNAL; ROOM TEMPERATURE;

ADULT; BLOOD COMPONENT REMOVAL; BLOOD SPECIMEN COLLECTION; DRUG STABILITY; FEASIBILITY STUDIES; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; LONGITUDINAL STUDIES; MIDDLE AGED; TIME FACTORS;

EID: 41849104477     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2008.02.001     Document Type: Article

References (14)

1. Renehan A.G., Zwahlen M., Minder C., et al. Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 363 (2004) 1346-1353
2. Hunter D.J., Riboli E., Haiman C.A., et al. A candidate gene approach to searching for low-penetrance breast and prostate cancer genes. Nat Rev Cancer 5 (2005) 977-985
3. Jones J.I., and Clemmons D.R. Insulin-like growth-factors and their binding-proteins - biological actions. Endocr Rev 16 (1995) 3-34
4. Kaaks R., and Lukanova A. Energy balance and cancer: the role of insulin and insulin-like growth factor-I. Proc Nutr Soc 60 (2001) 91-106
5. Van der V., Postma D.S., Timens W., et al. Acute effects of cigarette smoking on inflammation in healthy intermittent smokers. Respir Res 6 (2005) 22
6. Ayache S., Panelli M., Marincola F.M., and Stroncek D.F. Effects of storage time and exogenous protease inhibitors on plasma protein levels. Am J Clin Pathol 126 (2006) 174-184
7. Elmlinger M.W., Zwirner M., and Kuhnel W. Stability of insulin-like growth factor (IGF)-I and IGF binding protein (IGFBP)-3 measured by the IMMULITE (R) automated chemiluminescence assay system in different blood specimens. Clin Lab 51 (2005) 145-152
8. Ellis M.J., Livesey J.H., and Evans M.J. Hormone stability in human whole blood. Clin Biochem 36 (2003) 109-112
9. Kristal A.R., King I.B., Albanes D., et al. Centralized blood processing for the Selenium and Vitamin E Cancer Prevention Trial: effects of delayed processing on carotenoids, tocopherols, insulin-like growth factor-I, insulin-like growth factor binding protein 3, steroid hormones, and lymphocyte viability. Cancer Epidemiol Biomark Prev 14 (2005) 727-730
10. Harris T.G., Strickler H.D., Yu H., et al. Specimen processing time and measurement of total insulin-like growth factor-I (IGF-I), free IGF-I, and IGF binding protein-3 (IGFBP-3). Growth Horm IGF Res 16 (2006) 86-92
11. Hankinson S.E., Willett W.C., Colditz G.A., et al. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet 351 (1998) 1393-1396
12. Riboli E., Hunt K.J., Slimani N., et al. European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr 5 (2002) 1113-1124
13. Giovannucci E., Pollak M., Liu Y., et al. Nutritional predictors of insulin-like growth factor I and their relationships to cancer in men. Cancer Epidemiol Biomark Prev 12 (2003) 84-89
14. Toniolo P., Bruning P.F., Akhmedkhanov A., et al. Serum insulin-like growth factor-I and breast cancer. Int J Cancer 88 (2000) 828-832